1. Introduction {#sec1}
===============

Azoospermia is characterized by the complete absence of sperm in the ejaculate, affecting up to 15% of men seeking an infertility evaluation. Approximately 60% of cases of azoospermia are caused by primary or secondary hypogonadism, termed nonobstructive azoospermia (NOA) [@bib1]. Possible etiologies span a spectrum including genetic disorders or local testicular insults [@bib2], [@bib3] that result in impaired spermatogenesis or disruption of the hypothalamic-pituitary-testis (HPT) axis. The conditions leading to NOA represent some of the most challenging of infertility management.

Although the underlying cause of NOA may be occasionally correctable (i.e., hypogonadotrophic hypogonadism), most of these patients will require advanced reproductive technologies. With the introduction of *in vitro* fertilization (IVF) and intracytoplasmic sperm injection (ICSI) in the 1990s, many of these men can now father their own biologic children. IVF-ICSI combined with sperm extraction techniques are now considered standard practice and are conducted routinely worldwide.

For successful IVF-ICSI only a few viable sperm are required. In those patients with NOA, even very low levels of spermatogenesis can be exploited with surgical sperm extraction. Several techniques to retrieve sperm from the testes have been described, each with a unique set of advantages and disadvantages. In this review we summarize the surgical management of NOA and seek to clarify the implications of each approach.

2. Initial evaluation {#sec2}
=====================

A diagnosis of azoospermia is made after two separate semen analyses demonstrate the lack of spermatozoa in centrifuged specimens. An interval of at least 3 weeks should be allowed to pass between samples. It is important to rule out possible collection error or retrograde ejaculation when interpreting samples with low volumes (less than 1.5 mL). Once azoospermia is confirmed, one must differentiate between obstructive or nonobstructive etiologies.

A thorough history and physical examination provide the basis for further testing. A focused history investigates the inherent endocrine and exocrine function of the testes. Symptoms consistent with low testosterone may represent deficiencies in androgen production, often found in conjunction with NOA. A prior history of paternity should not be considered specific to either form of azoospermia. The clinician should also inquire about risk factors that may help guide further evaluation ([Table 1](#tbl1){ref-type="table"}).Table 1Risk factors for azoospermia.Type of azaspermianRisk factorsNonobstructive azoospermiaCryptorchidismDelayed pubertyChemotherapy or radiationTestosterone replacement therapyAnabolic steroid abuseHistory of orchitis (mumps)Toxin exposure (heavy metals, pesticides)  Obstructive azoospermiaPrior scrotal surgeriesInguinal hernia repairRecurrent respiratory tract infection (cystic fibrosis, Young syndrome)Pelvic/scrotal traumaReproductive malformation (prostatic cyst, absence of the vasa deferentia)History of epididymitisHistory of prostatitis

A detailed physical exam will often secure the diagnosis. The general exam can be useful in detecting stigmata of an endocrinopathy or genetic abnormality with particular awareness to gynecomastia and signs of impaired virilization. Careful attention should be paid to the scrotal exam. Surgical scars in the scrotum and inguinal region may provide evidence for prior surgery. Palpation of the spermatic cord allows the identification of possible varicoceles and to ensure the presence of both vasa deferentia. Decreased testicular volumes (below 15 mL) substantially raise suspicion for NOA. Finally, a digital rectal examination can be helpful in palpating obstructing midline cysts or fullness of the seminal vesicles.

Initial laboratory testing includes morning serum testosterone and follicle stimulating hormone (FSH) levels to help delineate the health of the Leydig and Sertoli cells, respectively. An FSH level above 7.6 mIU/mL supports an NOA diagnosis [@bib4]. Any abnormalities on initial screening should prompt a full evaluation of the HPT axis. Classically, NOA patients will have normal volume, normal pH, azoospermic semen analyses with small-volume testes and an elevated FSH. Karyotype and Y chromosome microdeletion testing should be obtained in any patient with suspected NOA as chromosomal abnormalities are common in this population [@bib5].

3. Evidence acquisition {#sec3}
=======================

A Medline search was conducted using the following search terms: nonobstructive azoospermia, sperm retrieval, testicular sperm extraction, fine needle aspiration, fine-needle mapping, testicular sperm aspiration, microdissection testicular sperm extraction, and cryopreservation. This search aimed to identify randomized, observational and descriptive studies describing the surgical management of NOA patients. As no randomized trials were available, observational and descriptive studies are discussed in this review.

A total of four techniques were commonly addressed and are described below, including testicular sperm aspiration (TESA), traditional testicular sperm extraction (TESE), fine needle aspiration (FNA) mapping, and microdissection testicular sperm extraction (microTESE). Two adjunctive procedures -- cryopreservation and the role of varicocelectomy -- are also discussed in the context of NOA management.

4. Evidence synthesis {#sec4}
=====================

4.1. TESA {#sec4.1}
---------

Testicular sperm can be retrieved via percutaneous aspiration of testicular tissue. This technique was initially described for diagnostic purposes before it was adapted as a therapeutic approach [@bib6]. The sample is acquired by aspirating through a fine (22-gauge) or large bore (18-gauge) needle after puncturing the testis through the scrotal skin. Samples of testicular parenchyma are subsequently immersed in human tubal fluid medium and mechanical disruption is performed [@bib7].

The success of sperm procurement with this approach has been evaluated by several studies. Lewin et al. [@bib8] treated 85 men with NOA via TESA and reported a sperm retrieval rate (SRR) of 58.8%. Khadra et al. [@bib9] evaluated the outcomes of 84 men who underwent TESA and reported an SRR of 53.6%. Patients in this cohort who failed TESA then proceeded to open testicular biopsy in a rescue effort at sperm recovery. The TESA-only group had a higher fertilization rate (62% *vs.* 48%) but this difference did not significantly impact clinical pregnancy rates (40% *vs*. 32%, *p* \> 0.05).

TESA offers a modest SRR permitting IVF-ICSI. In some centers, TESA has become the initial option given its minimally invasive approach and relatively small risk for parenchymal damage and testicular tissue loss. The procedure can be done with local anesthesia, mitigating the need for a full operating room while preserving the comfort of the patient [@bib10]. Minor side effects were described including hematocele and post-operative orchialgia, typically managed with oral analgesics [@bib8], [@bib9], [@bib11]. However, despite its safety, low cost, and ease, controlled studies have shown a much lower success rate compared with the more invasive procedures described below [@bib12].

4.2. TESE {#sec4.2}
---------

In order to improve the SRR in men with NOA, a larger sample of testicular tissue can be harvested and processed. TESE achieves this goal through open testicular biopsy via either a single or multi-site approach. This technique is more invasive as compared to TESA, requiring scrotal exploration. A small incision in the tunica albuginea is created avoiding any vessels, and the testis is gently compressed causing protrusion of the parenchyma. The extruded seminiferous tubules are excised and processed in a similar fashion as TESA [@bib7]. Additional samples can be collected from the same incision or via separate sites if more tissue is required.

Available literature regarding TESE has stratified SRRs based upon underlying testicular histopathology since this information is readily available. Su et al. [@bib13] reported a total SRR of 58% in 81 men who underwent TESE. Results varied substantially by histological pattern, with the highest SRR in the group with hypospermatogenesis as opposed to maturation arrest (MA) or Sertoli cell only (SCO) (79%, 47%, and 29%, respectively). In another report, Hauser et al. [@bib12] attempted TESE in a group of 87 patients, successfully procuring sperm in 64% of the overall cohort. The SRR stratified by histology was 100% in hypospermatogenic males, with a considerable drop to only 46% and 33% in MA and SCO, respectively.

A recent paper by Abdel Raheem et al. [@bib14] found a strong correlation between the presence of tubules with spermatozoa on histopathologic evaluation and success during TESE. In patients with hypospermatogenesis there was a 100% SRR with TESE, in contrast to only 24% in SCO, corroborating previous reports. The authors went on to suggest attempting pre-emptive TESE prior to the start of IVF-ICSI. Results will provide histologic information and any recovered sperm can be cryopreserved for use during egg retrieval. For those patients in whom sperm could not be found at initial TESE, the histopathologic findings can help stratify those who may be candidates for repeat fresh TESE versus more invasive procedures (e.g., microTESE), or consideration of donor sperm backup at the time of oocyte retrieval.

Differing SRRs have been reported depending upon underlying patient risk factors. A recent study from Marcelli et al. [@bib15] evaluated 142 patients with a history of cryptorchidism and found an overall SRR of 65% at the time of TESE. This study also showed that the age at orchidopexy did not influence SRR. Reasonable success using TESE has also been demonstrated in those individuals with Klinefelter syndrome. Vernaeve et al. [@bib16] studied 50 non-mosaic Klinefelter patients and reported a 48% SRR. A systematic review by Fullerton et al. [@bib17] included 373 men with Klinefelter syndrome who were managed using various surgical modalities. They reported a 42% SRR in the group that underwent TESE.

Given the heterogeneity of testicular spermatogenesis, the rationale of a single biopsy site as opposed to multiple biopsies has been questioned. A large study of 306 men by Amer et al. [@bib18] attempted to address this issue. They split their cohort into either single or multiple-site biopsy arms and demonstrated a higher success rate with multiple-site biopsies (38% *vs*. 49%). Although supportive for the multiple-site approach, their patients were not randomized which impedes definitive conclusions from their analysis.

TESE has been heralded to have better SRRs than TESA [@bib12]. However, complications occur more frequently with TESE, including scrotal hematomas and, rarely, testicular atrophy. Extratunical hematomas are observed in 5% of patients and are usually self-limited [@bib19]. Intratunical hematomas, although often asymptomatic, can be seen on 82% of ultrasounds and may take up to 6 months to completely resolve. Testicular devascularization and resulting atrophy is uncommon, occurring in 3% of reported cases. This complication is commonly attributed to multiple-site TESE procedures since separate arteries can be interrupted [@bib20]. Although some reports show vascular damage from TESE, Schill et al. [@bib21] did not find significant differences between pre- and post-TESE testicular volumes (by ultrasound) in 39 patients.

4.3. FNA mapping {#sec4.3}
----------------

Despite efforts to improve TESE there remains a significant failure rate. The experience with multiple-site testicular biopsies has shown that spermatogenesis is not homogenous. There are areas in the testicular parenchyma where sperm production is preserved, even in those patients with severe histopathology. Unfortunately, performing multiple testicular biopsies may raise the risk of testicular atrophy.

In order to target biopsies for sperm retrieval and reduce the chances of deleterious effects, the concept of FNA mapping was introduced by Turek et al. [@bib22]. The initial mapping procedure is often conducted under local anesthesia in the office setting. The surgeon directs multiple percutaneous punctures into the testis with a fine (23-gauge) needle in an attempt to aspirate parenchyma and sample various regions of the testis. Up to 18 template-guided sites are sampled and analyzed for sperm. Any positive aspirates favor successful sperm retrieval at that location. Thus, a few targeted open testicular biopsies can be conducted without the additional risk of multiple blind attempts [@bib23]. When FNA mapping confirms multiple sites with sperm, the reported success of TESE reaches 99% in a single surgeon\'s experience. If few areas demonstrate spermatogenesis, TESE success remains favorable with SRR approaching 90%. In the case of zero or one positive sampling, the success of TESE is debatable and more invasive procedures should be considered [@bib24].

Regarding outcomes, FNA mapping has proven safe, with one series showing no hematomas on follow-up ultrasounds [@bib22]. Moreover, there were no reported cases of testicular atrophy, no significant decrease in testosterone, or appreciable changes in testicular volumes 3 months following the procedure [@bib25]. In a heterogeneous group of 56 patients, FNA mapping demonstrated an SRR of approximately 70% [@bib26].

4.4. MicroTESE {#sec4.4}
--------------

In an attempt to further optimize testicular SRRs over those achieved with TESE, microTESE was developed in an effort to capitalize on success rates of multi-site excisional biopsy while aiming to limit the amount of tissue excised. Initially described by Schlegel [@bib27], he postulated that bivalving the testis and using optical magnification would allow the surgeon to minimize testicular trauma, maximize exposure for a complete exploration and dissection of the seminiferous tubules, and identify specific regions that might harbor preserved spermatogenesis.

The testis is delivered via a scrotal incision. With the assistance of the operating microscope, a transverse hemispheric incision is made into the tunica albuginea with an attempt to avoid transection of subtunical vessels. The testicle is then gently bivalved to expose the seminiferous tubules. The operating microscope is utilized at 20--40× magnification to identify plump and opaque seminiferous tubules that are more likely to contain sperm. In circumstances that initially fail to provide retrievable sperm, the testis can be completely surveyed and dissected in an effort to maximize any yield. Again, if sperm are not found, the surgeon proceeds to the contralateral testis in a similar fashion.

This technique has been shown to provide a better SRR than single or multi-site TESE. Despite its invasive nature, the optical magnification allows for rational tissue sampling and typically results in less overall tissue removal. Superior hemostasis can also be achieved since blood vessels can be directly visualized and either avoided or cauterized with the bipolar microforceps, decreasing risk of vascular injury and resulting atrophy. In one of the initial descriptions of the technique, a retrieval rate of 63% was obtained when compared to 45% for traditional TESE [@bib27]. Amer et al. [@bib28] directly compared microTESE with TESE by performing one procedure on one testis and the counter technique on the opposite side. This study reported similar results with an improvement in SRR (30% with TESE *vs*. 47% with microTESE).

Testicular histology also correlates with SRRs for microTESE. In one series, patients with SCO had yields of 22% with microTESE as compared to 13% using multi-site TESE [@bib29]. In another series with 460 patients SRR via microTESE was 81% in those with hypospermatogenesis, 44% with MA, and 41% with SCO as the predominant histologic pattern [@bib30].

One group investigated the use of microTESE as a salvage procedure following multiple unsuccessful TESE attempts. They reported that SRRs were not adversely affected following one or two prior TESE attempts. However, three or four previous TESE procedures did lead to decreased retrieval rates with microTESE, although spermatozoa were still found in 23% of these patients [@bib31].

Given the significant costs of IVF-ICSI and the emotional toll that accompanies a treatment cycle, multiple attempts have been made to develop predictors of SRR. A multi-institutional cohort of 1026 men was analyzed by Ramasamy and colleagues [@bib32] for this purpose. Although multiple parameters were found to correlate with favorable SRR, no indicator was found to be accurate enough to allow for meaningful clinical decisions. Even testicular volume has been found to be a poor predictor in regards to SRR. Bryson et al. [@bib33] evaluated the impact of testicular volume on microTESE success. They observed that NOA patients with severe testis atrophy, specifically with testicular volumes of 2 mL or less, had the same SRR as patients with volumes above 10 mL (55% *vs*. 55%).

### 4.4.1. Subpopulation success rates with microTESE {#sec4.4.1}

The specific populations identified within the Ramasamy cohort have also been separately studied with promising results. Patients with a history of cryptorchidism can achieve good retrieval rates with microTESE. Raman and Schlegel [@bib2] reported on 38 men submitted to 47 microTESE attempts with a resulting 74% SRR. This same cohort achieved clinical pregnancy in 46% of those with procured sperm. Contrary to a prior study, it was noted that SRR is related to the age at which orchidopexy was performed. Patients who had sperm successfully retrieved had typically undergone orchidopexy by 10 years of age. Another study from a similar cohort demonstrated a 64% SRR and 38% live birth rate [@bib34].

MicroTESE has also proven successful in those patients with non-mosaic Klinefelter syndrome. An initial report evaluated 42 patients with successful sperm extraction in 29 of the subjects (69% SRR). A total of 21 live births resulted from IVF-ICSI cycles that utilized the retrieved sperm [@bib35]. Another study addressed predictors of sperm retrieval within this population, revealing that subjects who responded to testosterone optimization (using aromatase inhibitors, selective estrogen receptor modulators, and/or human chorionic gonadotropin) had better SRRs (77% *vs*. 55%) [@bib36]. Fullerton et al. [@bib17] reviewed cases reported in the literature and identified 101 live births from Klinefelter syndrome patients who had sperm extracted via TESE or microTESE. All babies born were genetically normal.

With increasing frequency older men are becoming interested in family building. A retrospective study evaluated 1066 men with NOA and stratified them based upon age at the time of microTESE. The two groups had a mean age of 57 and 43, respectively. This report did not show a negative relationship between age and SRR, and on the contrary, older patients had higher rates of sperm retrieval (73% *vs*. 56%) [@bib37]. Although this is a retrospective series, this study shows that microTESE provides a reasonable option for the older male seeking fertility in the setting of NOA. However, the converse may be true in patients with Klinefelter syndrome. From a study of 74 patients, Klinefelter patients with successful sperm retrieval were significantly younger, an important finding to consider when counseling this subpopulation [@bib38].

### 4.4.2. MicroTESE complications {#sec4.4.2}

Complications of microTESE include hematoma and intratesticular fibrosis. In a series of 60 patients who underwent the procedure, 15% had intratesticular hypoechoic focal lesions on post-operative ultrasound. When followed with serial ultrasounds the rate reduced to 6% at 1 month and completely resolved by 6 months of follow-up [@bib28]. Similarly, a study with a cohort of 100 men demonstrated a hematoma rate of 12% on 1-month ultrasound, dropping to 2.5% at 6 months post-operatively [@bib39]. Ramasamy et al. [@bib30] reported a higher frequency of hematoma after microTESE, demonstrating a positive finding in 44% of patients who underwent ultrasound 3 months following the procedure. Again, nearly all of these hematomas had resolved by 6 months. More worrisome was a description of segmental devascularization that was discovered in four patients. None of these patients was ultimately found to have permanent vascular changes. In a large meta-analysis, although sonographic complications seemed higher, there were no differences in clinically evident complications between conventional TESE and microTESE [@bib40].

In those patients from whom large amounts of testicular parenchyma must be sampled, microTESE has been found to potentially result in atrophy and impaired testis function. Okada et al. [@bib39] reported decreased testicular volumes in two of 80 men who underwent microTESE. However, this finding was not corroborated by Amer et al. [@bib28] who reported that testicular volumes remained unchanged in 116 patients. Ramasamy et al. [@bib30] reported a 20% decrease of serum testosterone shortly after the procedure; however, serum levels returned to pre-procedural levels in 85% and 95% of men at 12 and 18 months, respectively. It should be mentioned that in the subpopulation of patients with Klinefelter syndrome, testosterone levels may remain decreased for longer periods of time as demonstrated by Takada et al. [@bib41].

A recent meta-analysis comparing conventional TESE with microTESE utilized the data from seven independent studies. The data, although predominately retrospective, did favor microTESE (54% *vs.* 33% SRR) [@bib40]. Interestingly, patients with hypospermatogenesis may not experience as much of a benefit given that conventional TESE can already achieve high SRRs. Often, however, a histopathothologic diagnosis is not known prior to sperm retrieval attempt.

4.5. Cryopreservation {#sec4.5}
---------------------

IVF-ICSI can be performed using frozen-thawed sperm. The use of cryopreserved sperm has logistical advantages and eliminates the need for concurrent oocyte and sperm retrievals. Unfortunately survival rates for frozen testicular sperm have been low in historical studies [@bib42]. In addition, IVF-ICSI outcomes may be impaired as Aoki et al. [@bib43] demonstrated in a retrospective evaluation of 92 cycles. Laboratory pregnancy rates (60% *vs.* 49.1%), clinical pregnancy rates (56.4% *vs.* 41.2%), and live birth rates (48.7% *vs.* 31.2%) were each higher in the fresh versus the frozen groups.

Recent data have questioned the superiority of fresh samples. Karacan and colleagues [@bib44] evaluated the outcome of 337 IVF-ICSI cycles in which 129 employed frozen testicular sperm. There was no difference in clinical pregnancy or live birth rates. Tavukcuoglu et al. [@bib45] evaluated the impact of frozen sperm in 39 IVF-ICSI cycles compared to fresh testicular sperm in 43 cycles. Again, there was no significant difference observed in clinical pregnancy or live birth rates.

A current systematic review included 10 studies assessing fertilization rates and 11 that evaluated clinical pregnancy rates. In total, 574 cycles were analyzed, 299 of which were conducted with frozen sperm. Results show that outcomes using frozen-thawed testicular sperm do not differ compared with freshly extracted sperm in terms of fertilization or live birth rates [@bib46]. At this time a consensus has not been met, and therefore use of frozen testicular sperm remains a debated topic.

4.6. Varicocelectomy in NOA {#sec4.6}
---------------------------

Varicocele repair has a controversial role in men with NOA. There are some authors who advocate that repair can result in an improvement of spermatogenesis and may possibly return sperm to the ejaculate, or at least improve SRRs during an extraction attempt. Others report that these data represent only a transient reemergence of spermatogenesis as is observed in some azoospermic patients without varicocele. In an initial report of microsurgical varicocelectomy, a small series of 27 patients with NOA and palpable varicocele demonstrated post-operative sperm on semen analysis in 33% of subjects. In this series one patient achieved spontaneous conception. Six of these patients reverted to azoospermia within 6 months following the procedure [@bib47]. Another small study included 23 men with non-palpable varicoceles. Similarly, following repair 30% of the group had return of motile sperm to the ejaculate. One patient conceived spontaneously and two others underwent successful ICSI using ejaculated samples [@bib48].

Abdel-Meguid [@bib49] attempted to study the effects of varicocele repair when patients were stratified by histopathologic diagnosis. By taking a testicular biopsy at the time of varicocelectomy they demonstrated reversal of azoospermia in 53% and 50% of men with hypospermatogenesis and MA, respectively. There was no improvement in those with SCO. A meta-analysis including 233 patients with NOA from 11 studies reported return of motile ejaculated sperm in 39% of men following varicocelectomy. Success rates were more favorable in patients with hypospermatogenesis (54%) or MA (42%) than SCO (11%). Moreover, 11 spontaneous pregnancies were reported [@bib50].

In contrast, one study described equivalent SRRs in those who underwent varicocelectomy as opposed to no intervention. Additionally, only 9.6% of men with varicocele repair had enough sperm return to the ejaculate to avoid subsequent surgical sperm retrieval [@bib51]. The lack of controlled and randomized studies weakens the data and represents the major criticism for the use of varicocelectomy as an adjunct. Varicocele repair may benefit some patients with NOA but definitive data will need to be acquired before this subgroup can be fully elucidated.

5. Conclusion {#sec5}
=============

Over the past several decades, treatment of men with NOA has benefited from an expanding knowledge base and the concomitant development of refined surgical techniques. Once impossible, men with NOA can now realistically hope to father their own biologic children. Reasonable pregnancy rates can be achieved using a variety of surgical approaches that vary from office-based percutaneous procedures to technically demanding microsurgery. Many couples have been given hope with these procedures, although there remains a proportion of men who will not have successful treatment. Future advances in the field will help diminish this group as our understanding of NOA evolves.
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